Summary:
- This article reports on a new study that investigates the use of a novel gene therapy approach to treat a rare genetic disorder called Duchenne muscular dystrophy (DMD).
- The researchers developed a virus-based vector that can deliver a healthy version of the dystrophin gene, which is mutated in DMD patients, to muscle cells.
- Initial tests in animal models showed that this gene therapy was able to restore dystrophin production and improve muscle function, suggesting it could be a promising treatment option for DMD patients.